Groundbreaking study reveals potential of spinal cord stimulation to improve mobility in patients with muscle-wasting disease. (AP/University of Pittsburgh Health Sciences via UPMC)
- Spinal cord stimulation shows promise in improving mobility for patients with spinal muscle atrophy.
- Participants experienced increased walking distance and improved muscle function during the month-long study.
- Researchers plan to conduct longer studies to further explore the potential of this innovative treatment.
Share
WASHINGTON — Three people with a muscle-destroying disease destined to worsen got a little stronger – able to stand and walk more easily – when an implanted device zapped their spinal cord.
On Wednesday, researchers reported what they called the first evidence that a spine-stimulating implant already being tested for paralysis might also aid neurodegenerative diseases like spinal muscle atrophy – by restoring some muscle function, at least temporarily.
“These people were definitely not expecting an improvement,” said Marco Capogrosso, an assistant professor at the University of Pittsburgh who led the research. Yet over the month-long pilot study, “they were getting better and better.”
Related Story: RFK Jr. on Track to Become US Health Secretary With Key GOP Support
Understanding Spinal Muscle Atrophy
Spinal muscle atrophy or SMA is a genetic disease that gradually destroys motor neurons, nerve cells in the spinal cord that control muscles. That leads muscles to waste away, especially in the legs, hips and shoulders and sometimes those involved with breathing and swallowing. There is no cure. A gene therapy can save the lives of very young children with a severe form of the disease, and there are some medicines to slow worsening in older patients.
Stimulating the spinal cord with low levels of electricity has long been used to treat chronic pain but Capogrosso’s team also has tested it to help people paralyzed from strokes or spinal cord injury move their limbs unaided. While turned on, it zaps circuits of dormant nerves downstream of the injury to activate muscles.
Related Story: Community Health System Announces $30M Milestone for Neuroscience Institute
Promising Results in Pilot Study
Then Capogrosso wondered if that same technology might help SMA in a similar way — by revving up related sensory nerves so they wake up damaged muscle cells, helping them move to combat wasting.
The Pitt researchers implanted electrodes over the lower spinal cord of three adults with SMA and tested their muscle strength, fatigue, range of motion and changes in gait and walking distance when the device was firing and when it was turned off.
It didn’t restore normal movement but with just a few hours of spinal stimulation a week, all quickly saw improvements in muscle strength and function, researchers reported in the journal Nature Medicine.
Patient Experience and Observations
“With a progressive disease you never get any better,” said study participant Doug McCullough, 57, of Franklin Park, New Jersey. “Either you’re staying stable or getting worse. So having any improvement is just a really surreal and very exciting benefit.”
All three participants significantly increased how far they could walk in six minutes, and one who initially couldn’t stand from a kneeling position could by the study’s end, Capogrosso said. And McCullough’s gait changed so that each step was about three times longer.
“They get less fatigued so they can walk for longer,” Capogrosso said. “Even a person this many years into the disease can improve.”
Intriguingly, researchers found the improvements didn’t disappear as soon as the stimulator was switched off, though they did fade as participants were tracked after the study ended.
McCullough said even when the stimulator was turned off, some nights his legs “would just feel supercharged.”
Related Story: Justice Department Curtails Prosecutions for Blocking Reproductive Health Care ...
Future Implications and Ongoing Research
While he understood that the device had to be removed at the study’s end, he was disappointed. He said there were some lingering benefits at his six-week checkup, but none after six months.
Neuroscientist Susan Harkema, who led pioneering studies of stimulation for spinal cord injuries while at the University of Louisville, cautioned the new study is small and short but called it an important proof of concept. She said it’s logical to test the technique against a list of muscle-degenerating diseases.
“Human spinal circuitry is very sophisticated – it’s not just a bunch of reflexes controlled by the brain,” said Harkema, now with the Kessler Foundation, a rehabilitation research nonprofit. “This is a very solid study, an important contribution to move forward.”
At Pitt, Capogrosso said some small but longer studies are getting underway.
RELATED TOPICS:
US Postal Service Reverses Ban on Hong Kong-China Packages
10 minutes ago
Valley Crime Stoppers’ Most Wanted Person of the Day: Audrey Ann Hathorn
15 minutes ago
Pam Bondi Is Sworn in as Attorney General. DOJ Braces for Major Shakeup.
25 minutes ago
Migrants Are Deported to India on US Military Plane
2 hours ago
Costa’s Bipartisan Bills Boost Funding for Recharge Projects
5 hours ago
Judge Says Fresno Can Change Street Names: Cesar Chavez Blvd Lawsuit Tossed
16 hours ago
The Aga Khan, Spiritual Leader of Ismaili Muslims and a Philanthropist, Dies at 88
17 hours ago
49ers Star Tight End George Kittle Is the NFL 2024 Salute to Service Award Winner